As of 2025-05-15, the EV/EBITDA ratio of Pharmagreen Biotech Inc (PHBI) is -4.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PHBI's latest enterprise value is 1.09 mil USD. PHBI's TTM EBITDA according to its financial statements is -0.25 mil USD. Dividing these 2 quantities gives us the above PHBI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2025-05-13 | -4.38 |
| 2025-05-12 | -4.11 |
| 2025-05-09 | -4.38 |
| 2025-05-08 | -4.38 |
| 2025-05-07 | -4.38 |
| 2025-05-06 | -4.64 |
| 2025-05-05 | -4.91 |
| 2025-05-02 | -4.91 |
| 2025-05-01 | -4.91 |
| 2025-04-30 | -4.91 |
| 2025-04-29 | -5.18 |
| 2025-04-28 | -5.18 |
| 2025-04-24 | -5.45 |
| 2025-04-23 | -5.45 |
| 2025-04-22 | -4.91 |
| 2025-04-21 | -4.91 |
| 2025-04-17 | -4.91 |
| 2025-04-16 | -5.18 |
| 2025-04-15 | -5.18 |
| 2025-04-14 | -5.18 |
| 2025-04-11 | -4.91 |
| 2025-04-10 | -4.91 |
| 2025-04-09 | -4.64 |
| 2025-04-08 | -4.38 |
| 2025-04-07 | -5.71 |
| 2025-04-04 | -5.71 |
| 2025-04-03 | -5.71 |
| 2025-04-02 | -5.71 |
| 2025-04-01 | -5.71 |
| 2025-03-31 | -5.71 |
| 2025-03-28 | -5.45 |
| 2025-03-27 | -4.91 |
| 2025-03-26 | -6.25 |
| 2025-03-25 | -5.71 |
| 2025-03-24 | -5.98 |
| 2025-03-21 | -5.18 |
| 2025-03-20 | -5.18 |
| 2025-03-19 | -5.18 |
| 2025-03-18 | -5.18 |
| 2025-03-17 | -4.64 |
| 2025-03-14 | -5.18 |
| 2025-03-13 | -4.91 |
| 2025-03-12 | -4.91 |
| 2025-03-11 | -4.91 |
| 2025-03-10 | -4.91 |
| 2025-03-07 | -4.38 |
| 2025-03-06 | -4.38 |
| 2025-03-05 | -4.64 |
| 2025-03-04 | -4.38 |
| 2025-03-03 | -4.38 |